Sleep

December 20th 2024

Weight Loss Drug Tirzepatide Now Approved for Sleep Apnea in Adults With Obesity

By Laura Joszt, MA

December 18th 2024

ICYMI: Highlights From SLEEP 2024

December 10th 2024

Mind the Gap: Addressing Pediatric Sleep Disparities and the Role of Sleep Variability

December 7th 2024

Strength and Stamina: Patients With OSA Benefit From Combined Exercise Regimens

Video Interviews

View All

July 3rd 2024

Dr Michael Thorpy: The Exciting Future of Orexin Agonists for Idiopathic Hypersomnia

June 11th 2024

Dr Melissa Jones: Still a Ways to Go for AI in Sleep Research

September 25th 2023

Part 3: Advances in Sodium Oxybate Provide Options for Various Patient Populations, Says Dr Michael Thorpy

September 18th 2023

Part 2: Certain Patients Could Benefit From High-Sodium Medications, Says Dr Michael Thorpy

September 7th 2023

Part 1: Dr. Michael Thorpy Emphasizes Low-Sodium Therapy Options for Sleep Disorders

August 8th 2023

Dr Sheila Garland Highlights Lifestyle, Psychological Impacts of Cancer Treatments

July 25th 2023

Dr Dayna Johnson Emphasizes the Need for Community Feedback in Sleep Health

July 21st 2023

Dr Judite Blanc Discusses Digging Deeper, Getting to the Root of Sleep Health

July 4th 2023

Dr Judite Blanc: Sleep Needs, Poor Sleep Consequences Vary Between Children and Adults

June 21st 2023

OHSU’s Dr Andrew McHill Discusses How Best to Optimize Sleep Hygiene Practices

Continuing Medical Education

View All

The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression

1.0 Credit / Neurology

1.0 Credit / Immunology, Neurology

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1 Credit / Cardiology, Neurology

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

August 21, 2025 | 1:00 PM ET & 8:00 PM ET

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

1.0 Credit / Immunology, Pulmonology/Respiratory

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

Overview and Burden of Migraine

0.5 Credit / Neurology

The Role of the Pharmacist Migraine Management

0.5 Credit / Neurology

The Evolving Treatment Landscape of Migraine

0.5 Credit / Neurology

1.5 Credits / Neurology, Psychiatry

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Immunization, Infectious Disease, Pulmonology

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunology, Pulmonology

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Pulmonology

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

More News

Restless legs syndrome remains one of the more common sleep and movement disorders | image credit: Andrey Popov - stock.adobe.com

November 30th 2024

Heat-Cold Therapy: A Drug-Free Solution to Improve Sleep in Restless Legs Syndrome

This analysis provides much-needed robust data on the efficacy of heat-cold therapy for mitigating discomfort and insomnia in restless legs syndrome (RSL).

Tooth loss | Image Credit: © valiantsin-stock.adobe.com

November 23rd 2024

Edentulism May Heighten Sleep Apnea Risk

Jared Kaltwasser

A systematic review has found a potential link between edentulism and sleep apnea risk, although the authors said differences in study designs prohibited a meta-analysis.

Sleepless woman suffering | Image Credit: ©- terovesalainen stock.adobe.com

November 10th 2024

Researchers Find Higher Risk of Insomnia With Undiagnosed Asthma

AJMC Contributor

Based on their findings, the researchers suggest a potential need for screening for coexisting sleep disorder symptoms in patients with respiratory symptoms.

Narcolepsy and idiopathic hypersomnia are each characterized by excessive daytime sleepiness | image credit: ARMMY PICCA - stock.adobe.com

November 7th 2024

Novel Orexin 2 Receptor Agonist Shows Promise for Management of Narcolepsy and Idiopathic Hypersomnia

Brendon Yee, PhD, professor and respiratory and sleep physician, Woolcock Institute of Medical Research, discusses the success of ALKS 2680, an investigational oral selective orexin 2 receptor agonist.

Pregnant women may experience insomnia | image credti: JenkoAtaman - stock.adobe.com

October 25th 2024

Kimberly Rath, PharmD

Both music combined with sleep hygiene and sleep hygiene alone significantly improved pregnancy related insomnia, a new study finds.

Psoriasis may increase one's risk of developing sleep apnea | image credit: SNAB - stock.adobe.com

October 17th 2024

Patients With Psoriasis Face Increased Risk of Obstructive Sleep Apnea, Study Finds

Kimberly Rath, PharmD

Research further shows a significant association between patients with psoriasis and an increased incidence of obstructive sleep apnea (OSA).

Zinc may help individuals get better sleep, but research in this area provides mixed conclusions | image credit: Ron Dale - stock.adobe.com

October 8th 2024

Zinc's Link to Sleep Quality Remains Unclear, Further Studies Needed

A systematic review analyzing sleep quality and the impact of zinc supplements reveals glaring gaps in knowledge in this area despite suggested benefits, demonstrating the need for future research.

Proactive strategies that place more value on nurses' ability to get quality rest is an important part of being able to deliver quality patient care | image credit: New Africa - stock.adobe.com

September 26th 2024

Insomnia, Presenteeism Put Patient Care at Risk: A Call to Prioritize Nurses' Sleep Quality, Well-Being

A recent data analysis draws correlations between nurses’ experience of insomnia and presenteeism, and the impact these factors have on patient care.

Little research has been conducted on the impact of compensatory sleep and cardiovascular health | image credit: stokkete - stock.adobe.com

September 21st 2024

Catching Up on Sleep on Weekends Links to 20% Lower Risk of Developing Heart Disease

Chelsie Derman

People with the most weekend catch-up sleep had a 20% lower risk of heart disease, especially those who were sleep-deprived during the week.

Magnesium-L-Threonate could provide more benefits for sleep quality | image credit: Aleksander - stock.adobe.com

September 18th 2024

Study: Magnesium-L-Threonate Improves Objective, Subjective Sleep Quality

Jared Kaltwasser

Though magnesium has long been seen as a potential sleep aid, the authors say the new form of magnesium salt may provide a clearer benefit.

Idiopathic hypersomnia belongs to a group referred to as the central disorders of hypersomnolence, which are classified by excessive daytime sleepiness | image credit: South House Studio - stock.adobe.com

September 17th 2024

Review: Idiopathic Hypersomnia Carries Considerable Burden and Remains Poorly Defined

A systematic review on diagnostic challenges and burden related to idiopathic hypersomnia gave insights into the extensive difficulties associated with the condition.

August 30th 2024

More Drug Does Not Always Lead to More Efficacy: Dr Mark Bleackley on the Progress of the RePOSA Study

Mark Bleackley, PhD, Incannex, discusses the notable and surprising observations from the ongoing RePOSA study, and the developmental challenges they have encountered with their cannabinoid pharmacotherapy for patients with obstructive sleep apnea.

Physical activity is a crucial factor for identifying risk of metabolic-associated fatty liver disease | image credit: Rawpixel.com - stock.adobe.com

August 16th 2024

Physical Activity Outweighs Sleep Duration in Lowering MAFLD Risk

Chelsie Derman

A new study found physical activity held more weight in the link between the joint exposure of sleep duration, metabolic equivalent of task, and Healthy Eating Index (HEI)-2015 and metabolic-associated fatty liver disease (MAFLD).

Daytime sleepiness is symptom many adults and children with idiopathic hypersomnia experience | image credit: Svyatoslav Lypynskyy - stock.adobe.com

August 14th 2024

Never Give Up on Your Diagnosis: Caitlin Kindberg's Message to Patients With Idiopathic Hypersomnia

Pearl Steinzor Kyle Munz

Caitlin Kindberg, a patient advocate from Nashville, Tennessee, discusses her experience finding proper treatment for idiopathic hypersomnia and the challenges associated with living with this condition.

Consumer-oriented sleep trackers are not yet advanced enough to produce data that can improve health outcomes | image credit: Gefo - stock.adobe.com

August 8th 2024

Don't Put Too Much Stock in Consumer Sleep Devices, Yet: Dr Christopher Depner

Kyle Munz Pearl Steinzor

Christopher Depner, PhD, assistant professor of health and kinesiology, University of Utah, speaks to the current reliability of wearable sleep devices to impact health outcomes, privacy concerns, and more.

July 22nd 2024

Dr Mark Bleackley Addresses Lack of Pharmacotherapies in OSA, Need for IHL-42X

Mark Bleackley, PhD, chief scientific officer of Incannex, discusses in further detail the need for a pharmacotherapy like IHL-42X in obstructive sleep apnea (OSA) and the medication's underlying mechanisms.

July 16th 2024

Dr Ron Grunstein Discusses Outcomes, Future Direction of ALKS 2680 Trial for Narcolepsy Type 1

Pearl Steinzor Kyle Munz

Ron Grunstein, MD, PhD, head of sleep and circadian research, Woolcock Institute of Medical Research, details results from the ALKS 2680 trial and the study's next steps.

July 9th 2024

Dr Mark Bleackley: New Medication to Benefit Patients With Obstructive Sleep Apnea

Mark Bleackley, PhD, chief scientific officer, Incannex, details the progress of the ongoing RePOSA trial, which is assessing the safety and efficacy of IHL-42X in patients with obstructive sleep apnea (OSA).

Dr Thorpy on Challenges and Treatments in Idiopathic Hypersomnia

June 27th 2024

Idiopathic Hypersomnia Is Not a Solitary Condition

Kyle Munz Pearl Steinzor

Michael Thorpy, MD, professor of neurology, Albert Einstein College of Medicine explores the current treatment landscape of idiopathic hypersomnia and the associated challenges with approving new medication for this condition.

Low-sodium oxybate contains over 90% less sodium than a high-sodium oxybate regimen | Image Credit: Nickpd - stock.adobe.com

June 25th 2024

Low-Sodium Oxybate: An Equally Effective but Safer Alternative to High-Sodium Oxybate for Narcolespy

A prospective study concluded that patients with narcolepsy can safely switch from a high-sodium oxybate to a low-sodium oxybate to manage their symptoms.

June 14th 2024

The Role of Orexin Agonists in Idiopathic Hypersomnia: Dr Michael Thorpy

Kyle Munz Pearl Steinzor

Michael Thorpy, MD, professor of neurology, Albert Einstein College of Medicine, explored the mechanism of action in orexin agonists, which has been indicated for idiopathic hypersomnia.

Infections Altering Brain, Sleep Disorder Concept | image credit: Matthieu - stock.adobe.com

May 29th 2024

Immunological Events Indicated in Onset of Hypersomnolence Disorders, Study Finds

Findings from a retrospective study suggested a possible causal relationship between prior infection and the development of hypersomnolence disorders such as narcolepsy and idiopathic hypersomnia, but more research is needed.

Group of Friends, Popularity Model | image credit: Davide Angelini - stock.adobe.com

May 13th 2024

A study assessing adolescents' self-reported sleep behavior and social factors unearthed a relationship between individual popularity and their sleep patterns.

Modeled CBT Process | image credit: safriibrahim - stock.adobe.com

May 6th 2024

Patients With Insomnia or Suspected Comorbid Sleep Apnea Respond Positively to Cognitive Behavioral Therapy Program

A secondary analysis investigating the efficacy of a digital, interactive cognitive behavioral therapy program for insomnia (CBTi) demonstrated the positive impacts of the program for patients with insomnia or a high risk of co-morbid insomnia and sleep apnea (COMISA).

Alarm Clock Sitting Next to Dreaming Individual | image credit: yavdat - stock.adobe.com

May 1st 2024

Limited Association Between 1-Night Sleep Restriction and Cognitive Performance

A recent meta-analysis drew limited conclusions about the impact of 1-night sleep restriction on cognitive function, stressing the need for further research consideration.

Polysomnography Concept | image credit: RFBSIP - stock.adobe.com

April 25th 2024

Single-Channel EOG Shown to Be Reliable for Automatic Sleep Staging in Various Sleep Disorders

A large cohort study demonstrated the validity and reliability of single-channel electro-oculography (EOG) for sleep-stage classification.

What We’re Reading: Drug Shortages Reach Record High; Americans Struggling With Sleep; Combatting Viral Hepatitis

April 15th 2024

What We’re Reading: Record High Drug Shortages; Americans' Sleep Struggles; Combatting Viral Hepatitis

AJMC Staff

The University of Utah Drug Information Service reports an unprecedented rise in shortages; cultural ethos and modern pressures contribute to sleep deprivation across the nation; rising death rates underscore the urgent need for expanded access to prevention and treatment measures

Nasal Spray | image credit: PixieMe - stock.adobe.com

April 11th 2024

Nasal Spray Alleviates Severity of Obstructive Sleep Apnea, Study Finds

A small, double-blind study has revealed the promise of the BAY2586116 nasal spray to help manage severe forms of obstructive sleep apnea and lower an individual’s morning blood pressure.

Woman Trying to Sleep Counting Sheep | image credit: Gstudio - stock.adobe.com

April 3rd 2024

Multiple Sleep Latency Test Aids in Diagnosis of Central Hypersomnia

A cluster analysis demonstrated the potential for the Multiple Sleep Latency Test (MSLT) to aid in the diagnosis of central hypersomnia and distinguish between idiopathic hypersomnia subgroups.

Smart Phone Controlling Man Like Puppet | image credit: rudall30 -stock.adobe.com

March 30th 2024

Study Reinforces Link Between Mobile Phone Addiction and Insomnia